Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSYR.L Regulatory News (SYR)

  • There is currently no data for SYR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FORM 8.3 - SYNERGY HEALTH PLC

27 Oct 2015 14:51

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose SYNERGY HEALTH PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 26 October 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? STERIS CORPORATION

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 2,786,373 4.71% 2,015 0.00%
(2) Cash-settled derivatives:
869 0.00% 2,786,358 4.71%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 2,787,242 4.71% 2,788,373 4.71%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 19 23.1250 GBP
ORD Purchase 22 23.0550 GBP
ORD Purchase 25 23.3600 GBP
ORD Purchase 36 22.9200 GBP
ORD Purchase 65 23.0950 GBP
ORD Purchase 65 23.1050 GBP
ORD Purchase 109 23.0650 GBP
ORD Purchase 111 23.0900 GBP
ORD Purchase 130 23.3100 GBP
ORD Purchase 130 23.0800 GBP
ORD Purchase 130 23.0350 GBP
ORD Purchase 130 23.1700 GBP
ORD Purchase 130 23.0100 GBP
ORD Purchase 130 23.0050 GBP
ORD Purchase 130 23.0400 GBP
ORD Purchase 131 23.2700 GBP
ORD Purchase 133 23.3050 GBP
ORD Purchase 139 22.9950 GBP
ORD Purchase 147 23.1200 GBP
ORD Purchase 148 22.9900 GBP
ORD Purchase 155 23.2900 GBP
ORD Purchase 157 23.3350 GBP
ORD Purchase 165 23.1150 GBP
ORD Purchase 167 23.2750 GBP
ORD Purchase 174 23.2100 GBP
ORD Purchase 182 23.1000 GBP
ORD Purchase 192 23.2500 GBP
ORD Purchase 203 23.1100 GBP
ORD Purchase 214 23.1300 GBP
ORD Purchase 215 23.3000 GBP
ORD Purchase 229 23.2350 GBP
ORD Purchase 250 23.2600 GBP
ORD Purchase 268 23.2477 GBP
ORD Purchase 283 23.2400 GBP
ORD Purchase 343 23.0300 GBP
ORD Purchase 345 23.2550 GBP
ORD Purchase 378 23.2950 GBP
ORD Purchase 549 23.2800 GBP
ORD Purchase 561 23.2450 GBP
ORD Purchase 572 23.2650 GBP
ORD Purchase 984 23.2318 GBP
ORD Purchase 1,058 23.2150 GBP
ORD Purchase 1,150 23.2063 GBP
ORD Purchase 2,072 23.1699 GBP
ORD Purchase 9,907 23.1762 GBP
ORD Purchase 250,486 23.2200 GBP
ORD Purchase 487,177 23.1628 GBP
ORD Purchase 927,803 23.2149 GBP
ORD Sale 19 23.1250 GBP
ORD Sale 22 23.0550 GBP
ORD Sale 25 23.3600 GBP
ORD Sale 36 22.9200 GBP
ORD Sale 65 23.0950 GBP
ORD Sale 65 23.1050 GBP
ORD Sale 109 23.0650 GBP
ORD Sale 111 23.0900 GBP
ORD Sale 130 23.1700 GBP
ORD Sale 130 23.0400 GBP
ORD Sale 130 23.0350 GBP
ORD Sale 130 23.0100 GBP
ORD Sale 130 23.0050 GBP
ORD Sale 130 23.3100 GBP
ORD Sale 130 23.0800 GBP
ORD Sale 131 23.2700 GBP
ORD Sale 133 23.3050 GBP
ORD Sale 139 22.9950 GBP
ORD Sale 147 23.1200 GBP
ORD Sale 148 22.9900 GBP
ORD Sale 155 23.2900 GBP
ORD Sale 157 23.3350 GBP
ORD Sale 165 23.1150 GBP
ORD Sale 167 23.2750 GBP
ORD Sale 174 23.2100 GBP
ORD Sale 176 23.0994 GBP
ORD Sale 182 23.1000 GBP
ORD Sale 192 23.2500 GBP
ORD Sale 203 23.1100 GBP
ORD Sale 214 23.1300 GBP
ORD Sale 215 23.3000 GBP
ORD Sale 229 23.2350 GBP
ORD Sale 250 23.2600 GBP
ORD Sale 283 23.2400 GBP
ORD Sale 327 23.1090 GBP
ORD Sale 343 23.0300 GBP
ORD Sale 345 23.2550 GBP
ORD Sale 378 23.2950 GBP
ORD Sale 549 23.2800 GBP
ORD Sale 557 23.2088 GBP
ORD Sale 561 23.2450 GBP
ORD Sale 572 23.2650 GBP
ORD Sale 763 23.0704 GBP
ORD Sale 1,058 23.2150 GBP
ORD Sale 1,380 23.1276 GBP
ORD Sale 1,521 23.0523 GBP
ORD Sale 4,730 23.0940 GBP
ORD Sale 6,773 23.0852 GBP
ORD Sale 7,794 23.0433 GBP
ORD Sale 26,195 23.2200 GBP
ORD Sale 50,000 23.1399 GBP
ORD Sale 68,158 23.1679 GBP
ORD Sale 150,000 23.2052 GBP
ORD Sale 216,990 23.2022 GBP
ORD Sale 314,684 23.1592 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD CFD Long 557 23.2088 GBP
ORD SWAP Short 89,224 23.2153 GBP
ORD CFD Short 732,489 23.2246 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 27 Oct 2015
Contact name: Rajesh Muthanna
Telephone number: 020 3555 4634

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151027006306/en/

Copyright Business Wire 2015

Date   Source Headline
2nd Nov 20153:51 pmRNSScheme Effective
2nd Nov 20152:55 pmRNSForm 8.3 - Steris Corporation
2nd Nov 20152:50 pmRNSForm 8.3 - Steris Corporation
2nd Nov 20151:55 pmRNSForm 8.3 - Steris Corporation
2nd Nov 20151:41 pmRNSForm 8.3 - Steris Corporation
2nd Nov 201512:08 pmRNSForm 8.3 - Synergy Health Plc
30th Oct 20152:47 pmRNSForm 8.3 - Steris Corporation
30th Oct 20152:07 pmRNSForm 8.3 - Steris Corporation
30th Oct 20151:58 pmRNSForm 8.3 - Steris Corporation
30th Oct 20151:00 pmRNSForm 8.3 - Synergy Health Plc
30th Oct 201511:25 amRNSForm 8.3 - Steris Corp
30th Oct 201511:22 amRNSForm 8.3 - Steris Corporation Replacement
30th Oct 201511:15 amRNSForm 8.3 - Steris Corporation
30th Oct 201511:00 amRNSHalf Yearly Report
30th Oct 201510:30 amRNSHalf Yearly Report
30th Oct 20157:00 amRNSForm 8.3 - Steris Corp.
30th Oct 20157:00 amRNSForm 8 (DD) - STERIS Corporation
29th Oct 20155:40 pmRNSForm 8.3 - Steris Corporation
29th Oct 20155:32 pmRNSForm 8.3 - Steris Corporation Plc
29th Oct 20152:18 pmRNSForm 8.3 - Steris Corporation
29th Oct 20151:52 pmRNSForm 8.3 - Steris Corporation
29th Oct 20151:50 pmRNSForm 8.3 - Steris Corp
29th Oct 20151:42 pmRNSForm 8.3 - Synergy Health Plc
29th Oct 20151:27 pmRNSForm 8.3 - Steris Corporation
29th Oct 20157:00 amBUSForm 8.3 - Synergy Health
28th Oct 20154:43 pmRNSResults of Court Hearing
28th Oct 20154:17 pmBUSForm 8.3 - SYNERGY HEALTH PLC
28th Oct 20153:29 pmRNSForm 8.3 - [Synergy Health Plc]
28th Oct 20153:24 pmRNSForm 8.3 - Synergy Health PLC
28th Oct 20153:00 pmRNSForm 8.3 - Synergy Health PLC
28th Oct 20152:47 pmBUSForm 8.3 - Synergy Health Plc
28th Oct 20152:09 pmRNSForm 8.3 - Steris Corporation
28th Oct 20151:36 pmRNSForm 8.3 - Synergy Health Plc
28th Oct 20151:21 pmRNSForm 8.3 - Steris Corp
28th Oct 20151:19 pmRNSForm 8.3 - Synergy Health Plc
28th Oct 20151:06 pmRNSForm 8.3 - Synergy Health PLC
28th Oct 20151:05 pmRNSForm 8.3 - Steris Corporation
28th Oct 201512:47 pmRNSForm 8.3 - Synergy Health Plc
28th Oct 201511:56 amRNSForm 8.3 - [Synergy Health Plc/Steris Corporation]
28th Oct 201511:52 amRNSForm 8.3 - [Synergy Health Plc/Steris Corporation]
28th Oct 201511:15 amRNSHolding(s) in Company
28th Oct 201510:29 amRNSForm 8 (DD) - Synergy Health plc
28th Oct 201510:27 amRNSForm 8 (DD) - Synergy Health plc
28th Oct 201510:25 amRNSForm 8 (DD) - Synergy Health plc
28th Oct 20157:30 amRNSSuspension Synergy Health Plc
28th Oct 20157:00 amRNSSuspension of trading and listing of Synergy Share
27th Oct 20154:14 pmBUSForm 8.3 - Synergy Health Plc
27th Oct 20153:25 pmRNSForm 8.3 - Synergy Health plc
27th Oct 20153:19 pmBUSForm 8.3 - Synergy Health Plc
27th Oct 20153:01 pmRNSForm 8.3 - Synergy Health PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.